RhumbLine Advisers’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $397K | Buy |
106,451
+9,792
| +10% | +$36.5K | ﹤0.01% | 2827 |
|
|
2025
Q1 | $267K | Sell |
96,659
-1,233
| -1% | -$3.4K | ﹤0.01% | 2955 |
|
|
2024
Q4 | $542K | Buy |
97,892
+13,479
| +16% | +$74.7K | ﹤0.01% | 2636 |
|
|
2024
Q3 | $704K | Sell |
84,413
-4,228
| -5% | -$35.3K | ﹤0.01% | 2474 |
|
|
2024
Q2 | $604K | Buy |
88,641
+29,659
| +50% | +$202K | ﹤0.01% | 2539 |
|
|
2024
Q1 | $387K | Buy |
58,982
+1,419
| +2% | +$9.31K | ﹤0.01% | 2816 |
|
|
2023
Q4 | $374K | Sell |
57,563
-1,566
| -3% | -$10.2K | ﹤0.01% | 2832 |
|
|
2023
Q3 | $297K | Buy |
59,129
+1,179
| +2% | +$5.93K | ﹤0.01% | 2941 |
|
|
2023
Q2 | $507K | Buy |
+57,950
| New | +$507K | ﹤0.01% | 2675 |
|